Product peg-derivatives -peptide-pegs

Home > products > peg-derivatives > peptide-pegs

Catalog	name	Description	price
R-M2-10106	FITC-SS31	FITC-SS31 is a fluorescein labeled derivative of SS-31 peptide, specifically designed for mitochondrial targeting studies. Advantages: Non membrane potential dependent targeting, does not affect mitochondrial function measurement, suitable for live cells and in vivo experiments. Application scenarios: Observation of mitochondrial dynamics (such as targeted changes under stress). Efficacy evaluation of oxidative stress models (such as H ₂ O ₂, t-BHP treatment). Mechanism research on mitochondrial related diseases such as sepsis and neurodegenerative diseases.	price>
R-M2-10111	Artesunate-PEG2k-SS-cRGDfk	Artesunate-PEG2k-SS-CRGDFk is a bifunctional complex primarily used for tumor targeted therapy and drug delivery systems. Application fields: Tumor treatment: used for delivering chemotherapy drugs, gene drugs, or nucleic acid drugs to improve efficacy and reduce side effects. Drug delivery system: As a modification material for nanocarriers such as liposomes and polymer micelles, it enhances targeting and stability.	price>
R-M1-8478	YIGSR-PEG-N3	The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.	price>
R-M1-8489	DMG-PEG-R8	DMG-PEG-R8,DMG-PEG-octaarginine for enhanced delivery of a bioactive molecule into cells. The PEG2K component may contribute to improved stability and solubility, while the R8 component may aid in cellular uptake.	price>
R-M2-10124	E7(EPLQLKM)-peg-DMG	E7(EPLQLKM)-peg-DMG/DMG-peg-E7(EPLQLKM)/-peg-DMG is an E7 derived peptide modified with PEG-DMG (di nutmeg glycerol polyethylene glycol), mainly used for targeted drug delivery and biological coupling research. Application: Targeted therapy: can be used in combination with chemotherapy drugs or siRNA for targeted therapy of HPV related tumors. Immune regulation: used in vaccine adjuvants or immunotherapy research, by activating the TLR pathway or regulating immune cell function. Biocoupling: As a connecting arm, it is used to construct peptide drug conjugates (PDCs) or nanocarriers.	price>
R-M1-8491	CY5-PEG-iRGD	CY5-PEG-iRGD is a compound designed for targeted delivery and imaging in cancer research. It consists of three components: CY5, a red fluorescent dye for visualization purposes; PEG, a biocompatible polymer that enhances stability and biocompatibility; and iRGD, a peptide sequence that specifically targets tumor cells.	price>
R-M1-8496	mpeg2000-SFSHHTPILPLCK	MPEG2000-SFSHHTPILPLCK is a peptide sequence composed of specific amino acids.	price>
R-M1-8507	SH-PEG3.4k-Angiopep2(TFFYGGSRGKRNNFKTEEYC)	SH-PEG3.4K-Angiopep2 is a linear heterobifunctional PEG reagent with thiol and Angiopep2 (TFFYGGSRGKRNNFKTEEYC).	price>
R-M1-8508	SH-PEG2k-Angiopep2(TFFYGGSRGKRNNFKTEEY)	SH-PEG2k-Angiopep2(TFFYGGSRGKRNNFKTEEY),SH-PEG2000-TFFYGGSRGKRNNFKTEEYC is a linear heterobifunctional PEG reagent with thiol and Angiopep2 (TFFYGGSRGKRNNFKTEEYC).	price>
R-M1-8518	Chol-PEG-CGSPWVRC	Cholesterol-PEG-CGSPWVRC is a complex compound that consists of multiple components linked together.The combination of cholesterol, PEG, and CGSPWVRC can be used to create drug delivery systems or nanocarriers. The cholesterol component allows for the incorporation of the compound within cell membranes, while the PEG component provides stability and prolonged circulation in the body. The CGSPWVRC peptide sequence may have specific binding or targeting properties, which can be utilized to deliver drugs or other therapeutic agents to specific tissues or cells. Overall, the complex compound has the potential to enhance drug delivery efficiency and improve therapeutic outcomes.	price>

...